Drug Type Small molecule drug |
Synonyms 8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine, Estazolam (JP17/USP/INN), A-47631 + [9] |
Target |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (25 Apr 1975), |
Regulation- |
Molecular FormulaC16H11ClN4 |
InChIKeyCDCHDCWJMGXXRH-UHFFFAOYSA-N |
CAS Registry29975-16-4 |
Start Date26 May 2024 |
Sponsor / Collaborator |
Start Date14 Nov 2022 |
Sponsor / Collaborator |
Start Date01 Jan 2021 |
Sponsor / Collaborator- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anxiety Disorders | CN | 01 Jan 1981 | |
Epilepsy | CN | 01 Jan 1981 | |
Sleep Initiation and Maintenance Disorders | JP | Teva Takeda Pharma Ltd.Startup | 25 Apr 1975 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | 36 | Sleep medication (+) | gkuzzvwnlt(umedtjlxqs) = tletihsekx audojpyooi (javctnlsqz, 8.7) View more | Negative | 07 Oct 2017 | ||
Sleep medication (-) | gkuzzvwnlt(umedtjlxqs) = itquxzxnof audojpyooi (javctnlsqz, 8.4) View more | ||||||
Phase 4 | 30 | benzodiazepine | obtarvfdtf(kkujshvdlj) = wwkbjnzpry wfibbjhhdh (ofdqmlgqpn, ojmpqyisdn - aoqoglbxso) View more | - | 26 Mar 2012 |